Dermata Therapeutics (DRMA)

• Market cap: $5.19M
• 1 day: 3.39%
• 5 days: -16.82%
• 1 month: -19.03%
• 3 months: -37.97%
• 6 months: -71.93%
• Year to date: -16.06%
• 1 year: -85%
• 5 years: -99.99%
• 10 years: -99.99%
• Sector: Healthcare
• Industry: Biotechnology

About: Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology for patients suffering with acne. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin.

Employees: 8